NCT02185768View on ClinicalTrials.gov

Chemoembolisation of Hepatocellular Carcinomas Not Subject to Interventive Care by Idarubicin-loaded Beads - IDASPHERE II

PHASE2CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

October 31, 2017

Study Completion Date

October 31, 2017

Conditions
Liver Cancer
Interventions
DRUG

idarubicin

DEVICE

Dc- Beads 300-500µm

Trial Locations (7)

21079

CHU - Hôpital François Mitterand, Dijon

34295

CHU St Eloi, Montpellier

49933

CHU d'ANGERS, Angers

69317

Hôpital La Croix Rousse, Lyon

69437

Hôpital Edouard Herriot, Lyon

Unknown

CHU Amiens, Amiens

06202

Hôpital de l'Archet II, Nice

All Listed Sponsors
lead

Federation Francophone de Cancerologie Digestive

OTHER

NCT02185768 - Chemoembolisation of Hepatocellular Carcinomas Not Subject to Interventive Care by Idarubicin-loaded Beads - IDASPHERE II | Biotech Hunter | Biotech Hunter